Matthew Frohn
Partner @ Longwall Venture
Oxford, United Kingdom
Matthew Frohn is a Series A investor at Longwall Venture in Oxford focused on Medical and Biopharma. Dr Matthew Frohn graduated from Oxford Brookes University with a degree in Cell and Molecular Biology followed by a D.Phil in Biochemistry from Oxford University. He worked on research collaborations with Astra Zeneca, and a short research post with a British Biotech subsidiary before joining Oxford Technology Management in 1999, the manager of theOxford Technology VCTs. He is particularly involved with its life science investments.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Matthew Frohn invests in
Stages Matthew Frohn invests in
Countries Matthew Frohn invests in
Investment Focus
Industry
- Medical 1 (100%)
- Biopharma 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Medical Device 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Caristo Diagnostics
|
Caristo Diagnostics is revolutionizing cardiovascular diagnostics and risk prediction with its advanced, AI-based CT imaging analysis tools. | $16.3M / Series A / Apr 17, 2023 |
Co-Investors
BGF Ventures
2 deals together
Oxford Science Enterprises
1 deal together
Oxford Investment Consultants LLP
1 deal together
Oxford University Innovation
1 deal together
About Longwall Venture
Longwall Ventures LLP is a venture capital firm specializing in growth capital, early stage, and start-up investments. It targets investing in science including physical science, life science, healthcare, security, media, business software, engineering, and technology companies based in United Kingdom. Longwall Ventures LLP was founded in 2011 andis based in Oxford, United Kingdom.
Longwall Venture Contacts
| Name | Phone | Socials | |
|---|---|---|---|
David Denny
Partner
|
|||
|
Matthew Frohn
Partner
|
|||
Rebecca Todd
Investment Director
|
|||
Michael Penington
Partner
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Matthew Frohn invest in?
Matthew Frohn invests primarily in Medical, Biopharma and Health Care startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Matthew Frohn last invest?
The most recent investment recorded for Matthew Frohn closed in Apr 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
